Literature DB >> 6747764

Chorioretinal coloboma and Joubert syndrome: a nonrandom association.

A M Laverda, O S Saia, P Drigo, E Danieli, M Clementi, R Tenconi.   

Abstract

Entities:  

Mesh:

Year:  1984        PMID: 6747764     DOI: 10.1016/s0022-3476(84)80133-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Joubert syndrome with polydactyly and optic coloboma in two sibs.

Authors:  A S Kher; A Chattopadhyay; A Divekar; K Khambekar; B A Bharucha
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

2.  Retinal detachment associated with coloboma of the choroid.

Authors:  K Wang; G F Hilton
Journal:  Trans Am Ophthalmol Soc       Date:  1985

3.  Joubert Syndrome: Ophthalmological Findings in Correlation with Genotype and Hepatorenal Disease in 99 Patients Prospectively Evaluated at a Single Center.

Authors:  Brian P Brooks; Wadih M Zein; Amy H Thompson; Maryam Mokhtarzadeh; Daniel A Doherty; Melissa Parisi; Ian A Glass; May C Malicdan; Thierry Vilboux; Meghana Vemulapalli; James C Mullikin; William A Gahl; Meral Gunay-Aygun
Journal:  Ophthalmology       Date:  2018-07-25       Impact factor: 12.079

4.  Electroretinographic Assessment in Joubert Syndrome: A Suggested Objective Method to Evaluate the Effectiveness of Future Targeted Treatment.

Authors:  Giulio Ruberto; Vincenzo Parisi; Chiara Bertone; Sabrina Signorini; Mauro Antonini; Enza Maria Valente; Federica Manzoni; Valentina Serpieri; Riccardo Fausto; Luciano Quaranta
Journal:  Adv Ther       Date:  2020-07-15       Impact factor: 3.845

5.  Visual Evoked Potentials in Joubert Syndrome: A Suggested Useful Method for Evaluating Future Approaches Targeted to Improve Visual Pathways' Function.

Authors:  Giulio Ruberto; Vincenzo Parisi; Chiara Bertone; Sabrina Signorini; Mauro Antonini; Enza Maria Valente; Federica Manzoni; Valentina Serpieri; Riccardo Fausto; Luciano Quaranta
Journal:  Adv Ther       Date:  2020-10-24       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.